This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, B. Articles by Lopaschuk, G. D. Search for Related Content PubMed PubMed Citation Articles by Liu, B. Articles by Lopaschuk, G. D.

(Circulation Research. 1996;79:940-948.)
© 1996 American Heart Association, Inc.

Articles

Cardiac Efficiency Is Improved After Ischemia by Altering Both the Source and Fate of Protons

Bin Liu, Alexander S. Clanachan, Richard Schulz, Gary D. Lopaschuk

the Cardiovascular Disease Research Group, Departments of Pediatrics (B.L., R.S., G.D.L.) and Pharmacology (B.L., A.S.C., R.S., G.D.L.), The University of Alberta, Edmonton, Canada.

Correspondence and reprint requests to Dr Gary D. Lopaschuk, 423 Heritage Medical Research Bldg, The University of Alberta, Edmonton, Alberta, Canada T6G 2S2. E-mail gary.lopaschuk@ualberta.ca.

Cardiac efficiency is decreased in hearts after severe ischemia. We determined whether reducing the production of H⁺ from glucose metabolism or inhibiting the clearance of H⁺ via Na⁺-H⁺ exchange could increase cardiac efficiency during reperfusion. This was achieved using dichloroacetate (DCA) to stimulate glucose oxidation and 5-(N,N-dimethyl)-amiloride (DMA) to inhibit Na⁺-H⁺ exchange, respectively. Isolated working rat hearts were subjected to 30 minutes of global ischemia and 60 minutes of reperfusion. Glycolysis and oxidation rates of glucose, lactate, and palmitate were measured. Recovery of cardiac work, O₂ consumption (MVO₂), and rates of acetyl-coenzyme A and ATP production during reperfusion were determined. After ischemia, cardiac work recovered to 35±5% of preischemic values in control hearts (n=23), although MVO₂, tricarboxylic acid (TCA) cycle activity, and ATP production from glycolysis and oxidative metabolism rapidly recovered to preischemic levels. This decrease in cardiac efficiency was accompanied by a substantial production of H⁺ from glucose metabolism. DCA caused a 2.2-fold increase in glucose oxidation, a 46±17% decrease in H⁺ production, a 1.6-fold increase in cardiac efficiency, and a 2.0-fold increase in cardiac work during reperfusion (n=17). Inhibition of Na⁺-H⁺ exchange with DMA did not alter TCA cycle activity and ATP production rates but did result in a 1.8-fold increase in cardiac efficiency and a 1.7-fold increase in cardiac work (n=12). These data show that cardiac efficiency and the contractile function after ischemia can be improved by either reducing the rate of H⁺ production from glucose metabolism during reperfusion or inhibiting the clearance of H⁺ via Na⁺-H⁺ exchange. Our data suggest that an increased requirement for ATP to restore ischemia-reperfusion–induced alterations in ion homeostasis contributes to the decrease in cardiac efficiency and contractile function after ischemia.

Key Words: glycolysis • glucose oxidation • lactate oxidation • Na⁺/H⁺ exchanger • fatty acid oxidation • reperfusion

This article has been cited by other articles:

				C. D. L. Folmes, C. S. Wagg, M. Shen, A. S. Clanachan, R. Tian, and G. D. Lopaschuk Suppression of 5'-AMP-activated protein kinase activity does not impair recovery of contractile function during reperfusion of ischemic hearts Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H313 - H321. [Abstract] [Full Text] [PDF]

				L. Zhou, H. Huang, T. A. McElfresh, D. A. Prosdocimo, and W. C. Stanley Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H939 - H945. [Abstract] [Full Text] [PDF]

				J. R. Ussher and G. D. Lopaschuk The malonyl CoA axis as a potential target for treating ischaemic heart disease Cardiovasc Res, July 15, 2008; 79(2): 259 - 268. [Abstract] [Full Text] [PDF]

				M. Gandhi, B. A. Finegan, and A. S. Clanachan Role of glucose metabolism in the recovery of postischemic LV mechanical function: effects of insulin and other metabolic modulators Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2576 - H2586. [Abstract] [Full Text] [PDF]

				I. Luptak, J. Yan, L. Cui, M. Jain, R. Liao, and R. Tian Long-Term Effects of Increased Glucose Entry on Mouse Hearts During Normal Aging and Ischemic Stress Circulation, August 21, 2007; 116(8): 901 - 909. [Abstract] [Full Text] [PDF]

				G. D. Lopaschuk, C. D.L. Folmes, and W. C. Stanley Cardiac Energy Metabolism in Obesity Circ. Res., August 17, 2007; 101(4): 335 - 347. [Abstract] [Full Text] [PDF]

				J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1107 - H1114. [Abstract] [Full Text] [PDF]

				J. Yang, N. Sambandam, X. Han, R. W. Gross, M. Courtois, A. Kovacs, M. Febbraio, B. N. Finck, and D. P. Kelly CD36 Deficiency Rescues Lipotoxic Cardiomyopathy Circ. Res., April 27, 2007; 100(8): 1208 - 1217. [Abstract] [Full Text] [PDF]

				C. D.L. Folmes and G. D. Lopaschuk Role of malonyl-CoA in heart disease and the hypothalamic control of obesity Cardiovasc Res, January 15, 2007; 73(2): 278 - 287. [Abstract] [Full Text] [PDF]

				J. R.B. Dyck, T. A. Hopkins, S. Bonnet, E. D. Michelakis, M. E. Young, M. Watanabe, Y. Kawase, K.-i. Jishage, and G. D. Lopaschuk Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury Circulation, October 17, 2006; 114(16): 1721 - 1728. [Abstract] [Full Text] [PDF]

				J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5'-AMP-activated protein kinase Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1883 - H1892. [Abstract] [Full Text] [PDF]

				C. D.L. Folmes, A. S. Clanachan, and G. D. Lopaschuk Fatty Acids Attenuate Insulin Regulation of 5'-AMP-Activated Protein Kinase and Insulin Cardioprotection After Ischemia Circ. Res., July 7, 2006; 99(1): 61 - 68. [Abstract] [Full Text] [PDF]

				J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF]

				N. Sambandam, D. Morabito, C. Wagg, B. N. Finck, D. P. Kelly, and G. D. Lopaschuk Chronic activation of PPAR{alpha} is detrimental to cardiac recovery after ischemia Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H87 - H95. [Abstract] [Full Text] [PDF]

				J. Y. Altarejos, M. Taniguchi, A. S. Clanachan, and G. D. Lopaschuk Myocardial Ischemia Differentially Regulates LKB1 and an Alternate 5'-AMP-activated Protein Kinase Kinase J. Biol. Chem., January 7, 2005; 280(1): 183 - 190. [Abstract] [Full Text] [PDF]

				Y. Burelle, R. B. Wambolt, M. Grist, H. L. Parsons, J. C. F. Chow, C. Antler, A. Bonen, A. Keller, G. A. Dunaway, K. M. Popov, et al. Regular exercise is associated with a protective metabolic phenotype in the rat heart Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1055 - H1063. [Abstract] [Full Text] [PDF]

				J. R.B. Dyck, J.-F. Cheng, W. C. Stanley, R. Barr, M. P. Chandler, S. Brown, D. Wallace, T. Arrhenius, C. Harmon, G. Yang, et al. Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation Circ. Res., May 14, 2004; 94(9): e78 - e84. [Abstract] [Full Text] [PDF]

				W. R. Tracey, J. L. Treadway, W. P. Magee, J. C. Sutt, R. K. McPherson, C. B. Levy, D. E. Wilder, L. J. Yu, Y. Chen, R. M. Shanker, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1177 - H1184. [Abstract] [Full Text] [PDF]

				G. D. Lopaschuk, R. Barr, P. D. Thomas, and J. R.B. Dyck Beneficial Effects of Trimetazidine in Ex Vivo Working Ischemic Hearts Are Due to a Stimulation of Glucose Oxidation Secondary to Inhibition of Long-Chain 3-Ketoacyl Coenzyme A Thiolase Circ. Res., August 8, 2003; 93 (3): e33 - e37. [Abstract] [Full Text] [PDF]

				M. Diamant, H. J. Lamb, Y. Groeneveld, E. L. Endert, J. W. A. Smit, J. J. Bax, J. A. Romijn, A. de Roos, and J. K. Radder Diastolic dysfunction is associatedwith altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus J. Am. Coll. Cardiol., July 16, 2003; 42(2): 328 - 335. [Abstract] [Full Text] [PDF]

				T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF]

				G. D. Lopaschuk and M. Marzilli Mode of Action of Trimetazidine and Other New Metabolic Agents in the Treatment of Ischemic Heart Disease Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 91 - 96. [PDF]

				R. K. Kudej, L. T. White, A. B. Kudej, S. F. Vatner, and E. D. Lewandowski Brief Increase in Carbohydrate Oxidation After Reperfusion Reverses Myocardial Stunning in Conscious Pigs Circulation, November 26, 2002; 106(22): 2836 - 2841. [Abstract] [Full Text] [PDF]

				L.J de Windt, K Cox, L Hofstra, and P.A Doevendans Molecular and genetic aspects of cardiac fatty acid homeostasis in health and disease Eur. Heart J., May 2, 2002; 23(10): 774 - 787. [Full Text] [PDF]

				H. Han, S. Hoffmann, K. Hu, and G. Ertl Angiotensin II subtype 1 (AT1) receptors contribute to ischemic contracture and regulate chemomechanical energy transduction in isolated transgenic rat ({alpha}MHC-hAT1)594-17 hearts Eur J Heart Fail, March 1, 2002; 4(2): 131 - 137. [Abstract] [Full Text] [PDF]

				Q. Liu, J. C. Docherty, J. C. T. Rendell, A. S. Clanachan, and G. D. Lopaschuk High levels of fatty acids delay the recoveryof intracellular pH and cardiac efficiency inpost-ischemic hearts by inhibiting glucose oxidation J. Am. Coll. Cardiol., February 20, 2002; 39(4): 718 - 725. [Abstract] [Full Text] [PDF]

				G. D. Lopaschuk, I. M. Rebeyka, and M. F. Allard Metabolic Modulation: A Means to Mend a Broken Heart Circulation, January 15, 2002; 105(2): 140 - 142. [Full Text] [PDF]

				C. Korvald, O. P. Elvenes, T. Myrmel, and D. G. Sorlie Cardiac dysfunction and inefficiency after substrate-enriched warm blood cardioplegia Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 555 - 564. [Abstract] [Full Text] [PDF]

				R. T. Smolenski, M. Amrani, J. Jayakumar, P. Jagodzinski, C. C. Gray, A. T. Goodwin, I. A. Sammut, and M. H. Yacoub Pyruvate/dichloroacetate supply during reperfusion accelerates recovery of cardiac energetics and improves mechanical function following cardioplegic arrest Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 865 - 872. [Abstract] [Full Text] [PDF]

				M. Taniguchi, C. Wilson, C. A. Hunter, D. J. Pehowich, A. S. Clanachan, and G. D. Lopaschuk Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1762 - H1769. [Abstract] [Full Text] [PDF]

				L. M. King, R. J. Sidell, J. R. Wilding, G. K. Radda, and K. Clarke Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1173 - H1181. [Abstract] [Full Text] [PDF]

				T. L. Broderick, W. R. Driedzic, M. Gillis, J. Jacob, and T. Belke Effects of Chronic Food Restriction and Exercise Training on the Recovery of Cardiac Function Following Ischemia J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 33B - 37. [Abstract] [Full Text]

				R. B. Wambolt, G. D. Lopaschuk, R. W. Brownsey, and M. F. Allard Dichloroacetate improves postischemic function of hypertrophied rat hearts J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1378 - 1385. [Abstract] [Full Text] [PDF]

				J. L. Griffin, L. T. White, and E. D. Lewandowski Substrate-dependent proton load and recovery of stunned hearts during pyruvate dehydrogenase stimulation Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H361 - H367. [Abstract] [Full Text] [PDF]

				E. D. Lewandowski Metabolic Mechanisms Associated With Antianginal Therapy Circ. Res., March 17, 2000; 86(5): 487 - 489. [Full Text] [PDF]

				P. F. Kantor, A. Lucien, R. Kozak, and G. D. Lopaschuk The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase Circ. Res., March 17, 2000; 86(5): 580 - 588. [Abstract] [Full Text] [PDF]

				C. Depre and H. Taegtmeyer Metabolic aspects of programmed cell survival and cell death in the heart Cardiovasc Res, February 1, 2000; 45(3): 538 - 548. [Abstract] [Full Text] [PDF]

				W. R. Ford, A. S. Clanachan, and B. I. Jugdutt Characterization of Cardioprotection Mediated by AT2 Receptor Antagonism After Ischemia-Reperfusion in Isolated Working Rat Hearts Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(3): 211 - 221. [Abstract] [PDF]

				E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF]

				C. Depre, J.-L. J. Vanoverschelde, and H. Taegtmeyer Glucose for the Heart Circulation, February 2, 1999; 99(4): 578 - 588. [Full Text] [PDF]

				H. Fraser, G. D. Lopaschuk, and A. S. Clanachan Assessment of glycogen turnover in aerobic, ischemic, and reperfused working rat hearts Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1533 - H1541. [Abstract] [Full Text] [PDF]

				Q. Liu, A. S. Clanachan, and G. D. Lopaschuk Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E392 - E399. [Abstract] [Full Text] [PDF]

				I. S. Ali, M. Gandhi, B. A. Finegan, A. Koshal, and A. S. Clanachan Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage Ann. Thorac. Surg., May 1, 1998; 65(5): 1303 - 1309. [Abstract] [Full Text] [PDF]

				W. R. Ford, A. S. Clanachan, G. D. Lopaschuk, R. Schulz, and B. I. Jugdutt Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1524 - H1531. [Abstract] [Full Text] [PDF]

				C. S. Apstein and H. Taegtmeyer Glucose-Insulin-Potassium in Acute Myocardial Infarction : The Time Has Come for a Large, Prospective Trial Circulation, August 19, 1997; 96(4): 1074 - 1077. [Full Text]

				G. D. Lopaschuk and W. C. Stanley Glucose Metabolism in the Ischemic Heart Circulation, January 21, 1997; 95(2): 313 - 315. [Full Text]